A randomized trial of rosuvastatin in the prevention of venous thromboembolism Academic Article uri icon

Overview

MeSH Major

  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • Venous Thromboembolism

abstract

  • In this trial of apparently healthy persons, rosuvastatin significantly reduced the occurrence of symptomatic venous thromboembolism. (ClinicalTrials.gov number, NCT00239681.)

publication date

  • April 30, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2710995

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa0900241

PubMed ID

  • 19329822

Additional Document Info

start page

  • 1851

end page

  • 61

volume

  • 360

number

  • 18